I47.1
Supraventricular tachycardia
Clinical Classification Guidelines
Medical Intelligence & Overview
Supraventricular tachycardia (SVT) is a condition characterized by an abnormally rapid heartbeat originating above the heart's ventricles. It can cause sudden episodes of rapid heart rate that may last from a few seconds to several hours. Though often alarming, SVT is usually not life-threatening and can often be managed effectively. This guide provides an overview of SVT, including its causes, symptoms, diagnosis, and treatment options, to help patients understand this condition better.
Causes & Symptoms
Clinical Causes: Electrical system irregularities in the heart, leading to abnormal rapid signals Structural heart abnormalities, such as an extra electrical pathway Certain medications that can influence heart rhythm Stimulants like caffeine, nicotine, or recreational drugs Electrolyte imbalances, such as abnormal levels of potassium or magnesium Stress or fatigue that may trigger episodes Underlying heart disease, including coronary artery disease or heart failure Previous heart surgery or invasive procedures affecting heart conduction pathways
Key Symptoms: Sudden episodes of rapid heartbeat that may feel like a racing or pounding sensation Palpitations or discomfort in the chest Shortness of breath or difficulty breathing Dizziness or lightheadedness Feeling faint or near fainting during episodes Weakness or fatigue Sometimes, SVT can occur without noticeable symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosing SVT involves a combination of medical history review, physical examination, and specialized tests. Healthcare providers may recommend:
Treatment Protocols: Management of SVT aims to control and prevent episodes, improve quality of life, and reduce risks. Treatment options typically include:
Clinical Advice & FAQs
Billing Guidance
Is I47.1 a billable ICD-10 code?
Yes, I47.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I47.1?
Clinical documentation must specify the nature of Supraventricular tachycardia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference